Relative Selectivity of Covalent Inhibitors Requires Assessment of Inactivation Kinetics and Cellular Occupancy: A Case Study of Ibrutinib and Acalabrutinib

Case Study - COVALfinder to Study Irreversible EGFR Drugs

Structure-Function Relationships of Covalent and Non-Covalent BTK Inhibitors. - Abstract - Europe PMC

Tyrosine Kinase: Most Up-to-Date Encyclopedia, News & Reviews

Frontiers Bruton's Tyrosine Kinase Inhibitors Impair FcγRIIA-Driven Platelet Responses to Bacteria in Chronic Lymphocytic Leukemia

Toward Atomistic Modeling of Irreversible Covalent Inhibitor Binding Kinetics

Covalent Modifiers: 2017

Frontiers Structure-Function Relationships of Covalent and Non-Covalent BTK Inhibitors

Structural and biophysical insights into the mode of covalent binding of rationally designed potent BMX inhibitors - RSC Chemical Biology (RSC Publishing) DOI:10.1039/D0CB00033G

Btk turnover in Ramos cells. Target occupancy as a function of time

Ibrutinib Inhibits Platelet Integrin αIIbβ3 Outside-In Signaling and Thrombus Stability But Not Adhesion to Collagen